Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients between the age group of 19-60 years of either sex presented with clinical features of VataRakta/ Gout. 2.Diagnosed and confirmed the case of VataRakta (Gout). 3.Patients have serum uric acid levels of more than 6mg/dl in females & more than 7mg/dl in males with or without any associated features like joint pain and inflammation.
Exclusion criteria
Exclusion criteria: 1.Patients below 19 years and above 60 years will be excluded 2.Patients suffering from other forms of Arthritis like Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Infective arthritis, etc. 3.Pregnant and lactating mother. 4.Subject showing the uric acid level above 9mg/dl. 5.Patients with evidence of malignancy & on chemotherapy drugs. 6.Patients having any disorders like Diabetes mellitus, Cardiac disease, CRF, ARF, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of Kokilakshadi Kashayam and Kaishore Guggulu will be noted in respective groups as per changes in subjective criteria on the 15th 30th day and 60th-day post-treatment and repeat lab investigation (CBC, ESR, CRP (Quantitative), Serum UA, Blood Urea, Serum Creatinine, RA Factor) will be done post-treatment.Timepoint: 30 days of treatment with follow up on 15th, 30th and 60th day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To Compare efficacy of Kokilakshadi Kashaya & Kaishore Guggulu after complete treatment & follow up of both groups. 2.Evalution of adverse effect of both drug will be done on each patient during & post treatment.Timepoint: Final result will be checked post treatment of all patients from both groups & will take approx 1 year 2) Adverse effects will be noted on each patient & each follow up till 60th day | — |
Countries
India
Contacts
Shri Krishna government ayurvedic college and hospital